aMe12 (R), n=2 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: ACh

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 253.5 96.0 491.0 100.0 250.5 542.5 32.0 1.0 - - 1766.5
1 8.0 - 0.5 - 19.5 162.5 18.5 0.5 - - 209.5
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 118.5
1 118.0
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 55
1 355

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 3533

Number of pre synapses: 419

Number of output connections: 1000

Coverage factor: 1.2

Columnar completeness: 0.67

Area completeness: 0.94

Cell size (columns): 372

Lobula

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#aMe12 (R) % % cumu.
0 Dm9 (R) Glu 1,007 503.5 27.8% 27.8%
1 R8p (R) His 404 202.0 11.1% 38.9%
2 R7p (R) His 237 118.5 6.5% 45.4%
3 MeVPMe13 (L) ACh 184 92.0 5.1% 50.5%
4 Dm8b (R) Glu 161 80.5 4.4% 54.9%
5 Dm2 (R) ACh 117 58.5 3.2% 58.2%
6 aMe4 (R) ACh 116 58.0 3.2% 61.4%
7 Mi10 (R) ACh 113 56.5 3.1% 64.5%
8 Dm8a (R) Glu 76 38.0 2.1% 66.6%
9 Mi15 (R) ACh 76 38.0 2.1% 68.7%
10 MeVPMe12 (L) ACh 74 37.0 2.0% 70.7%
11 Cm11d (R) ACh 65 32.5 1.8% 72.5%
12 Cm9 (R) Glu 55 27.5 1.5% 74.0%
13 Dm11 (R) Glu 47 23.5 1.3% 75.3%
14 R8_unclear (R) His 47 23.5 1.3% 76.6%
15 aMe17b (R) GABA 43 21.5 1.2% 77.8%
16 Cm11b (R) ACh 42 21.0 1.2% 78.9%
17 MeVPMe12 (R) ACh 41 20.5 1.1% 80.1%
18 R7_unclear (R) His 41 20.5 1.1% 81.2%
19 MeVPMe13 (R) ACh 38 19.0 1.0% 82.2%
20 aMe22 (R) Glu 36 18.0 1.0% 83.2%
21 MeVPLo2 (R) ACh 33 16.5 0.9% 84.2%
22 Tm5c (R) Glu 31 15.5 0.9% 85.0%
23 aMe30 (R) Glu 30 15.0 0.8% 85.8%
24 aMe2 (R) Glu 29 14.5 0.8% 86.6%
25 OA-AL2i3 (R) OA 29 14.5 0.8% 87.4%
26 aMe12 (R) ACh 15 7.5 0.4% 87.8%
27 aMe23 (R) unclear 15 7.5 0.4% 88.3%
28 aMe5 (R) ACh 15 7.5 0.4% 88.7%
29 MeVC11 (L) ACh 15 7.5 0.4% 89.1%
30 aMe17a (R) Glu 13 6.5 0.4% 89.4%
31 MeVP9 (R) ACh 13 6.5 0.4% 89.8%
32 MeVPMe7 (L) Glu 12 6.0 0.3% 90.1%
33 MeLo1 (R) ACh 11 5.5 0.3% 90.4%
34 OA-AL2i4 (R) OA 11 5.5 0.3% 90.7%
35 R7y (R) His 11 5.5 0.3% 91.0%
36 Cm31a (R) GABA 10 5.0 0.3% 91.3%
37 MeTu1 (R) ACh 10 5.0 0.3% 91.6%
38 MeVP8 (R) ACh 10 5.0 0.3% 91.9%
39 MeVPLo2 (L) ACh 10 5.0 0.3% 92.1%
40 Cm28 (R) unclear 9 4.5 0.2% 92.4%
41 Dm-DRA2 (R) Glu 8 4.0 0.2% 92.6%
42 MeVC20 (R) Glu 8 4.0 0.2% 92.8%
43 MeVC22 (R) Glu 8 4.0 0.2% 93.1%
44 Cm1 (R) ACh 7 3.5 0.2% 93.2%
45 Cm2 (R) ACh 7 3.5 0.2% 93.4%
46 Cm7 (R) Glu 7 3.5 0.2% 93.6%
47 Cm27 (R) Glu 6 3.0 0.2% 93.8%
48 Dm-DRA1 (R) Glu 6 3.0 0.2% 94.0%
49 R7d (R) His 6 3.0 0.2% 94.1%
50 R8y (R) His 6 3.0 0.2% 94.3%
51 Tm5b (R) ACh 6 3.0 0.2% 94.5%
52 aMe1 (R) GABA 5 2.5 0.1% 94.6%
53 aMe6c (R) Glu 5 2.5 0.1% 94.7%
54 Cm11a (R) ACh 5 2.5 0.1% 94.9%
55 Cm11c (R) ACh 5 2.5 0.1% 95.0%
56 Cm4 (R) Glu 5 2.5 0.1% 95.1%
57 MeTu3c (R) ACh 5 2.5 0.1% 95.3%
58 Mi1 (R) ACh 5 2.5 0.1% 95.4%
59 Tm30 (R) GABA 5 2.5 0.1% 95.6%
60 aMe17e (R) Glu 4 2.0 0.1% 95.7%
61 Cm3 (R) GABA 4 2.0 0.1% 95.8%
62 Cm8 (R) GABA 4 2.0 0.1% 95.9%
63 Dm20 (R) Glu 4 2.0 0.1% 96.0%
64 MeVPaMe2 (L) Glu 4 2.0 0.1% 96.1%
65 OA-AL2i1 (R) OA 4 2.0 0.1% 96.2%
66 Tm26 (R) ACh 4 2.0 0.1% 96.3%
67 5thsLNv_LNd6 (R) ACh 3 1.5 0.1% 96.4%
68 Cm20 (R) GABA 3 1.5 0.1% 96.5%
69 Cm26 (R) Glu 3 1.5 0.1% 96.6%
70 Cm30 (R) GABA 3 1.5 0.1% 96.7%
71 Cm31b (R) GABA 3 1.5 0.1% 96.7%
72 Cm33 (R) GABA 3 1.5 0.1% 96.8%
73 Cm35 (R) GABA 3 1.5 0.1% 96.9%
74 Dm12 (R) Glu 3 1.5 0.1% 97.0%
75 HBeyelet (R) His 3 1.5 0.1% 97.1%
76 MeVP14 (R) ACh 3 1.5 0.1% 97.2%
77 MeVP7 (R) ACh 3 1.5 0.1% 97.2%
78 R7R8_unclear (R) unclear 3 1.5 0.1% 97.3%
79 Tm20 (R) ACh 3 1.5 0.1% 97.4%
80 Tm39 (R) ACh 3 1.5 0.1% 97.5%
81 TmY5a (R) Glu 3 1.5 0.1% 97.6%
82 aMe12 (L) ACh 2 1.0 0.1% 97.6%
83 aMe17c (R) Glu 2 1.0 0.1% 97.7%
84 aMe6b (R) ACh 2 1.0 0.1% 97.7%
85 aMe9 (L) ACh 2 1.0 0.1% 97.8%
86 Cm10 (R) GABA 2 1.0 0.1% 97.9%
87 Cm12 (R) GABA 2 1.0 0.1% 97.9%
88 Cm21 (R) GABA 2 1.0 0.1% 98.0%
89 Cm5 (R) GABA 2 1.0 0.1% 98.0%
90 Dm10 (R) GABA 2 1.0 0.1% 98.1%
91 Dm4 (R) Glu 2 1.0 0.1% 98.1%
92 DNc01 (R) unclear 2 1.0 0.1% 98.2%
93 l-LNv (L) unclear 2 1.0 0.1% 98.2%
94 L2 (R) ACh 2 1.0 0.1% 98.3%
95 L5 (R) ACh 2 1.0 0.1% 98.3%
96 Lat3 (R) unclear 2 1.0 0.1% 98.4%
97 LT58 (R) Glu 2 1.0 0.1% 98.5%
98 MeTu3b (R) ACh 2 1.0 0.1% 98.5%
99 MeVC27 (L) unclear 2 1.0 0.1% 98.6%
100 MeVP1 (R) ACh 2 1.0 0.1% 98.6%
101 MeVP2 (R) ACh 2 1.0 0.1% 98.7%
102 MeVP20 (R) unclear 2 1.0 0.1% 98.7%
103 MeVP31 (R) ACh 2 1.0 0.1% 98.8%
104 MeVP43 (R) ACh 2 1.0 0.1% 98.8%
105 MeVPMe11 (R) Glu 2 1.0 0.1% 98.9%
106 Tm29 (R) Glu 2 1.0 0.1% 99.0%
107 Tm37 (R) Glu 2 1.0 0.1% 99.0%
108 Tm5a (R) ACh 2 1.0 0.1% 99.1%

Outputs

  instance NT total connections connections /#aMe12 (R) % % cumu.
0 5thsLNv_LNd6 (R) ACh 162 81.0 6.7% 6.7%
1 aMe30 (R) Glu 131 65.5 5.4% 12.1%
2 Tm37 (R) Glu 130 65.0 5.4% 17.4%
3 aMe4 (R) ACh 118 59.0 4.9% 22.3%
4 MeVPMe12 (R) ACh 117 58.5 4.8% 27.1%
5 LoVC23 (L) GABA 110 55.0 4.5% 31.6%
6 Tm30 (R) GABA 110 55.0 4.5% 36.2%
7 aMe6c (R) Glu 108 54.0 4.4% 40.6%
8 OA-AL2i3 (R) OA 91 45.5 3.7% 44.4%
9 aMe22 (R) Glu 79 39.5 3.3% 47.6%
10 Cm31a (R) GABA 62 31.0 2.6% 50.2%
11 Lat3 (R) unclear 58 29.0 2.4% 52.6%
12 Cm6 (R) GABA 49 24.5 2.0% 54.6%
13 MeVP7 (R) ACh 48 24.0 2.0% 56.6%
14 aMe24 (R) unclear 40 20.0 1.6% 58.2%
15 aMe3 (R) Glu 36 18.0 1.5% 59.7%
16 aMe5 (R) ACh 36 18.0 1.5% 61.2%
17 MeVPMe13 (R) ACh 36 18.0 1.5% 62.7%
18 Dm8a (R) Glu 35 17.5 1.4% 64.1%
19 aMe2 (R) Glu 34 17.0 1.4% 65.5%
20 l-LNv (R) unclear 34 17.0 1.4% 66.9%
21 aMe23 (R) unclear 33 16.5 1.4% 68.3%
22 MeVP9 (R) ACh 30 15.0 1.2% 69.5%
23 aMe1 (R) GABA 28 14.0 1.2% 70.7%
24 MeVC21 (R) Glu 27 13.5 1.1% 71.8%
25 MeVPaMe2 (R) Glu 26 13.0 1.1% 72.8%
26 MeVC20 (R) Glu 24 12.0 1.0% 73.8%
27 Dm8b (R) Glu 23 11.5 0.9% 74.8%
28 MeVP14 (R) ACh 23 11.5 0.9% 75.7%
29 aMe10 (R) ACh 22 11.0 0.9% 76.6%
30 Mi15 (R) ACh 21 10.5 0.9% 77.5%
31 MeVPMe3 (R) Glu 20 10.0 0.8% 78.3%
32 PLP231 (R) unclear 20 10.0 0.8% 79.2%
33 SLP250 (R) unclear 19 9.5 0.8% 79.9%
34 Cm11d (R) ACh 18 9.0 0.7% 80.7%
35 Cm8 (R) GABA 17 8.5 0.7% 81.4%
36 MeVPMe12 (L) ACh 17 8.5 0.7% 82.1%
37 KCg-s1 (R) unclear 16 8.0 0.7% 82.7%
38 Lawf1 (R) ACh 16 8.0 0.7% 83.4%
39 MeVPMe7 (R) Glu 16 8.0 0.7% 84.1%
40 SLP249 (R) unclear 16 8.0 0.7% 84.7%
41 aMe12 (R) ACh 15 7.5 0.6% 85.3%
42 aMe_TBD1 (R) unclear 15 7.5 0.6% 85.9%
43 Cm31b (R) GABA 15 7.5 0.6% 86.6%
44 aMe26 (R) ACh 13 6.5 0.5% 87.1%
45 MeVP8 (R) ACh 12 6.0 0.5% 87.6%
46 Mi19 (R) 5HT 12 6.0 0.5% 88.1%
47 Mi17 (R) GABA 11 5.5 0.5% 88.5%
48 aMe25 (R) unclear 10 5.0 0.4% 89.0%
49 Cm23 (R) Glu 10 5.0 0.4% 89.4%
50 MeVP48 (R) unclear 10 5.0 0.4% 89.8%
51 Cm26 (R) Glu 8 4.0 0.3% 90.1%
52 Dm11 (R) Glu 8 4.0 0.3% 90.4%
53 Cm11c (R) ACh 7 3.5 0.3% 90.7%
54 Cm21 (R) GABA 7 3.5 0.3% 91.0%
55 Lat1 (R) unclear 7 3.5 0.3% 91.3%
56 MeVPMe11 (R) Glu 6 3.0 0.2% 91.6%
57 aMe13 (R) unclear 5 2.5 0.2% 91.8%
58 aMe6a (R) ACh 5 2.5 0.2% 92.0%
59 Cm11a (R) ACh 5 2.5 0.2% 92.2%
60 KCg-d (R) unclear 5 2.5 0.2% 92.4%
61 MeLo1 (R) ACh 5 2.5 0.2% 92.6%
62 MeTu3b (R) ACh 5 2.5 0.2% 92.8%
63 MeTu3c (R) ACh 5 2.5 0.2% 93.0%
64 OA-AL2i4 (R) OA 5 2.5 0.2% 93.2%
65 Cm12 (R) GABA 4 2.0 0.2% 93.4%
66 Dm2 (R) ACh 4 2.0 0.2% 93.5%
67 DN1a (R) unclear 4 2.0 0.2% 93.7%
68 MeTu1 (R) ACh 4 2.0 0.2% 93.9%
69 MeVP25 (R) unclear 4 2.0 0.2% 94.0%
70 MeVP63 (R) GABA 4 2.0 0.2% 94.2%
71 SMP217 (R) unclear 4 2.0 0.2% 94.4%
72 Cm1 (R) ACh 3 1.5 0.1% 94.5%
73 Cm28 (R) unclear 3 1.5 0.1% 94.6%
74 Cm29 (R) GABA 3 1.5 0.1% 94.7%
75 L1 (R) Glu 3 1.5 0.1% 94.8%
76 MeVC22 (R) Glu 3 1.5 0.1% 95.0%
77 MeVP2 (R) ACh 3 1.5 0.1% 95.1%
78 MeVPMe4 (R) Glu 3 1.5 0.1% 95.2%
79 Tm5a (R) ACh 3 1.5 0.1% 95.3%
80 aMe12 (L) ACh 2 1.0 0.1% 95.4%
81 aMe15 (R) unclear 2 1.0 0.1% 95.5%
82 aMe17c (R) Glu 2 1.0 0.1% 95.6%
83 CL125 (R) unclear 2 1.0 0.1% 95.7%
84 Cm-DRA (R) ACh 2 1.0 0.1% 95.8%
85 Cm19 (R) GABA 2 1.0 0.1% 95.8%
86 Cm3 (R) GABA 2 1.0 0.1% 95.9%
87 Cm35 (R) GABA 2 1.0 0.1% 96.0%
88 Cm7 (R) Glu 2 1.0 0.1% 96.1%
89 Cm9 (R) Glu 2 1.0 0.1% 96.2%
90 Dm10 (R) GABA 2 1.0 0.1% 96.3%
91 Dm9 (R) Glu 2 1.0 0.1% 96.3%
92 Lat2 (R) unclear 2 1.0 0.1% 96.4%
93 MeVP1 (R) ACh 2 1.0 0.1% 96.5%
94 MeVP12 (R) ACh 2 1.0 0.1% 96.6%
95 MeVP15 (R) ACh 2 1.0 0.1% 96.7%
96 MeVP31 (R) ACh 2 1.0 0.1% 96.7%
97 MeVP35 (R) unclear 2 1.0 0.1% 96.8%
98 MeVP47 (R) unclear 2 1.0 0.1% 96.9%
99 MeVP57 (R) unclear 2 1.0 0.1% 97.0%
100 MeVPLo2 (R) ACh 2 1.0 0.1% 97.1%
101 MeVPLp1 (R) ACh 2 1.0 0.1% 97.2%
102 Mi10 (R) ACh 2 1.0 0.1% 97.2%
103 Mi16 (R) GABA 2 1.0 0.1% 97.3%
104 s-LNv (R) unclear 2 1.0 0.1% 97.4%
105 Tm36 (R) ACh 2 1.0 0.1% 97.5%
106 Tm38 (R) ACh 2 1.0 0.1% 97.6%
107 Tm5b (R) ACh 2 1.0 0.1% 97.7%
108 Tm5c (R) Glu 2 1.0 0.1% 97.7%